Search research articles
Contact Us
Filters
Showing results (111-120 of 143) with videos related to
Page
of 15
Sort By:
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|
September 1, 1983
[Ultrasonic diagnosis of multilocular echinococcosis of the liver]
T Okai, H Morimoto, K Morioka, et al.
AIDS Research and Human Retroviruses
|
July 13, 2000
Identification and characterization of differentially expressed mRNAs in HIV type 1-infected human T cells
A Ryo, Y Suzuki, M Arai, et al.
ESMO Open
|
August 30, 2021
A novel clinical prognostic index for patients with advanced gastric cancer: possible contribution to the continuum of care
K Shimozaki, I Nakayama, D Takahari, et al.
Glia
|
November 24, 1999
Serial analysis of gene expression in a microglial cell line
H Inoue, M Sawada, A Ryo, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Prognostic nutritional index as a prognostic marker in metastatic esophageal squamous-cell carcinoma treated with immune checkpoint inhibitor
K Yoshino, M Tamba, H Osumi, et al.
The American Journal of Cardiology
|
March 4, 1998
Right and left ventricular wall motion velocities as diagnostic indicators of constrictive pericarditis
T Oki, T Tabata, H Yamada, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Real-world clinical impact of first-line immune checkpoint inhibitor-based therapy in advanced esophageal squamous cell carcinoma
M Tamba, K Chin, H Osumi, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
The clinical utility of an mGPS and SII combined score in patients with advanced gastric cancer treated with nivolumab monotherapy
S Udagawa, A Ooki, H Osumi, et al.
ESMO Open
|
June 22, 2023
Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma
I Nakayama, D Takahari, K Chin, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Clinical efficacy of nivolumab-based therapy for HER2-negative diffuse-type advanced gastric or gastroesophageal junction adenocarcinoma with peritoneal dissemination
Y Suzuki, K Shimozaki, S Udagawa, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 143) with videos related to
Sort By:
Page
of 15
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|
September 1, 1983
[Ultrasonic diagnosis of multilocular echinococcosis of the liver]
T Okai, H Morimoto, K Morioka, et al.
AIDS Research and Human Retroviruses
|
July 13, 2000
Identification and characterization of differentially expressed mRNAs in HIV type 1-infected human T cells
A Ryo, Y Suzuki, M Arai, et al.
ESMO Open
|
August 30, 2021
A novel clinical prognostic index for patients with advanced gastric cancer: possible contribution to the continuum of care
K Shimozaki, I Nakayama, D Takahari, et al.
Glia
|
November 24, 1999
Serial analysis of gene expression in a microglial cell line
H Inoue, M Sawada, A Ryo, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Prognostic nutritional index as a prognostic marker in metastatic esophageal squamous-cell carcinoma treated with immune checkpoint inhibitor
K Yoshino, M Tamba, H Osumi, et al.
The American Journal of Cardiology
|
March 4, 1998
Right and left ventricular wall motion velocities as diagnostic indicators of constrictive pericarditis
T Oki, T Tabata, H Yamada, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Real-world clinical impact of first-line immune checkpoint inhibitor-based therapy in advanced esophageal squamous cell carcinoma
M Tamba, K Chin, H Osumi, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
The clinical utility of an mGPS and SII combined score in patients with advanced gastric cancer treated with nivolumab monotherapy
S Udagawa, A Ooki, H Osumi, et al.
ESMO Open
|
June 22, 2023
Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma
I Nakayama, D Takahari, K Chin, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Clinical efficacy of nivolumab-based therapy for HER2-negative diffuse-type advanced gastric or gastroesophageal junction adenocarcinoma with peritoneal dissemination
Y Suzuki, K Shimozaki, S Udagawa, et al.
Page
of 15